These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20947651)

  • 1. ¹³¹I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases.
    Jouneau S; Vauléon E; Caulet-Maugendre S; Polard E; Volatron AC; Meunier C; Tattevin P; Montani D; Garin E; Raoul JL; Delaval P
    Chest; 2011 Jun; 139(6):1463-1469. PubMed ID: 20947651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
    Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
    Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach.
    Oger E; Lavenu A; Bellissant E; Garin E; Polard E
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):956-63. PubMed ID: 21748824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal radiation by 131-iodine lipiodol in unresectable hepatocellular carcinoma.
    Tabone M; Carbonatto P; Calvo A; Pellerito R; Stasi M; Daperno M; Rocca R
    Dig Liver Dis; 2013 Nov; 45(11):962-3. PubMed ID: 23587497
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
    Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
    World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Intraarterial Lipiodol or ¹³¹I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial.
    Dumortier J; Decullier E; Hilleret MN; Bin-Dorel S; Valette PJ; Boillot O; Partensky C; Letoublon C; Ducerf C; Leroy V; Vuillez JP; Borson-Chazot F
    J Nucl Med; 2014 Jun; 55(6):877-83. PubMed ID: 24722530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
    Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
    Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-131-lipiodol therapy in hepatic tumours.
    Ahmadzadehfar H; Sabet A; Wilhelm K; Biersack HJ; Risse J
    Methods; 2011 Nov; 55(3):246-52. PubMed ID: 21664971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review.
    Naorungroj T; Naksanguan T; Chinthammitr Y
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S270-5. PubMed ID: 23590054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial.
    Guiu B; Jouve JL; Schmitt A; Minello A; Bonnetain F; Cassinotto C; Piron L; Cercueil JP; Loffroy R; Latournerie M; Wendremaire M; Lepage C; Boulin M
    J Hepatol; 2018 Jun; 68(6):1163-1171. PubMed ID: 29427728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience.
    Favelier S; Boulin M; Hamza S; Cercueil JP; Cherblanc V; Lepage C; Hillon P; Chauffert B; Krausé D; Guiu B
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1039-46. PubMed ID: 23224215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.
    Beppu T; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Ogura S; Kasai C; Kusagawa S; Nojiri K; Yoneda M; Fuke H; Yamamoto N; Takei Y; Fujimori M; Hasegawa T; Yamanaka T; Uraki J; Kashima M; Takaki H; Nakatsuka A; Yamakado K; Takeda K
    Anticancer Res; 2012 Nov; 32(11):4923-30. PubMed ID: 23155261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and prognostic factors after adjuvant
    Olesinski J; Mithieux F; Guillaud O; Hilleret MN; Lombard-Bohas C; Henry L; Boillot O; Walter T; Partensky C; Paliard P; Valette PJ; Vuillez JP; Borson-Chazot F; Scoazec JY; Dumortier J
    Ann Nucl Med; 2017 Jun; 31(5):379-389. PubMed ID: 28342103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Marubashi S; Miyamoto A; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Aozasa K; Monden M
    J Gastroenterol; 2004 Aug; 39(8):793-7. PubMed ID: 15338375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and short-term therapeutic effects of miriplatin-lipiodol suspension in transarterial chemoembolization (TACE) for hepatocellular carcinoma.
    Okabe K; Beppu T; Haraoka K; Oh-Uchida Y; Yamamura S; Tomiyasu S; Yamanaka T; Sano O; Masuda T; Chikamoto A; Fujiyama S; Baba H
    Anticancer Res; 2011 Sep; 31(9):2983-8. PubMed ID: 21868548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial.
    Chung AY; Ooi LL; Machin D; Tan SB; Goh BK; Wong JS; Chen YM; Li PC; Gandhi M; Thng CH; Yu SW; Tan BS; Lo RH; Htoo AM; Tay KH; Sundram FX; Goh AS; Chew SP; Liau KH; Chow PK; Tay KH; Tan YM; Cheow PC; Ho CK; Soo KC
    World J Surg; 2013 Jun; 37(6):1356-61. PubMed ID: 23463394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.